🇺🇸 FDA
Patent

US 7135192

Cationic lipid compositions targeting angiogenic endothelial cells

granted A61KA61K47/54A61K47/543

Quick answer

US patent 7135192 (Cationic lipid compositions targeting angiogenic endothelial cells) held by The Regents of the University of California expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/54, A61K47/543, A61K49/0032, A61K49/0041